Group Health Commission Economics for Brokers in India 2026: Premium Inflation, Loss Ratios, and the Real Cost of Servicing

Group health is the anchor product of Indian employee benefits broking and one of the largest premium pools in general insurance. Health has been the biggest line in the market for several years, group business contributes a large share of it, and brokers place the clear majority of corporate group health premium in the mid-market and large-account segments.

For a broker, the economics of this pool look deceptively attractive at headline level. Premium grows almost automatically: medical inflation of 12 to 15 percent annually, expanding cover (maternity enhancements, OPD attachments, mental-health inclusion, parental covers), and workforce growth in services sectors all push the number up. A book that renews at the same client count still grows 10 to 20 percent in premium terms in a typical year.

The catch is that brokerage does not follow premium mechanically. Since the IRDAI (Payment of Commission) Regulations, 2023 removed product-wise caps, group health commission is set by each insurer's board-approved policy inside the expenses-of-management envelope of the IRDAI (Expenses of Management, including Commission, of Insurers) Regulations, 2024, roughly 30 percent of gross written premium for general insurers and 35 percent for standalone health insurers. Group health is one of the loss-heaviest lines those envelopes have to accommodate, and insurers ration accordingly.

The result, visible across FY2024-25 and FY2025-26 renewals, is a widening gap between premium growth and brokerage growth on the same book. Indicatively, premium-weighted commission yields on corporate group health have drifted from the 7 to 10 percent range toward 4 to 7 percent, with large accounts settling lower or converting to fees. Premium up, yield down is the base case, and every strategy question in employee benefits broking starts from that arithmetic.

Why does 15 percent premium inflation not produce 15 percent brokerage growth? Four mechanisms drive the divergence.

1. Renewal repricing is a negotiation about total account cost. When an insurer seeks a 20 percent premium increase on a loss-making account, the corporate pushes back, and the pieces that give are benefit design (co-pays, room-rent caps, sub-limits) and distribution cost. Brokerage percentage cuts of 1 to 3 points are now a standard component of renewal settlements on deteriorated accounts.
2. Account-size migration. The fastest premium growth sits in large accounts, exactly where commission rates are lowest and net-of-brokerage fee structures are most common. Book mix shifts toward large accounts mechanically dilute the blended yield even when no individual rate changes.
3. Insurer EOM triage. An insurer near its EOM ceiling allocates commission where it buys profitable growth. Group health portfolios running combined ratios well above 100 do not qualify, so board-approved commission scales increasingly tie group health payout to account-level expected profitability.
4. Competitive undercutting. Group health remains the door-opener product for corporate relationships, and brokers chasing logos discount their own remuneration to win mandates, resetting the market rate downward one RFP at a time.

The compounding effect is material. A book earning 8 percent on INR 100 crore of premium in FY2023-24 produced INR 8 crore of brokerage. Three years later the same book at INR 140 crore of premium and a 5.5 percent blended yield produces INR 7.7 crore. Premium grew 40 percent; revenue fell. Meanwhile the servicing load, which scales with lives, claims, and endorsements rather than with premium, grew in line with the 40 percent, which is why the cost side of the ledger deserves as much attention as the yield side.

Corporate group health has long been priced thin, with incurred claims ratios on group portfolios frequently reported at 95 to 115 percent and individual accounts well above that. An account at a 110 percent claims ratio with 6 percent brokerage and the insurer's own expense load is unambiguously loss-making, and under EOM discipline the insurer cannot cross-subsidise it indefinitely.

Pushback arrives through predictable channels, and brokers who recognise them early keep control of the renewal.

• The burn-rate letter. Mid-term claims monitoring flags accounts trending past 80 to 85 percent burn by month eight, and the insurer opens the renewal conversation early with a correction agenda covering premium, benefit design, and brokerage together.
• Profitability-scaled commission. Board-approved policies increasingly grade group health commission by expected account outcome: full rate on accounts projected under 85 percent claims ratio, stepped reductions above, minimal rates on accounts renewing above 100 percent.
• Net quoting on corrections. On the worst accounts, insurers quote renewal net of brokerage entirely, telling the corporate to fund its broker separately if it values the service.
• Co-insurance reshuffles. Lead insurers under EOM pressure invite followers to take larger shares at lower distribution cost, and the broker's remuneration becomes part of the panel arithmetic.

The strategic response is not to defend the rate in the abstract but to change the account's trajectory. Brokers who bring claims-cost management to the table, network steering, case management on high-value hospitalisations, fraud referral, and honest plan design, can argue for remuneration on a stabilised account. On a book basis, a portfolio running five points better than market on claims ratio buys a materially stronger commission negotiation with every insurer on the panel.

Group health is the most operationally intensive product in commercial broking, and the cost of that intensity is the half of the unit economics brokers measure least. The indicative figures below come from employee benefits operating patterns on serviced corporate accounts.

Endorsements. Corporate workforces churn, and every join and leave is an endorsement: data validation, insurer submission, CD account balance check under Section 64VB, confirmation, and e-card follow-through. A 10,000-life account in IT or services generates 8,000 to 18,000 member movements a year. At even 15 to 25 minutes of handling time per movement across broker and coordination effort, endorsements alone consume one to three full-time staff on a single large account.

Claims desk. Group portfolios run 60 to 90 claims per 1,000 lives per year, so the same account produces 600 to 900 claims annually. Most flow through cashless channels, but a meaningful share need intervention: pre-authorisation delays, deduction disputes, document deficiencies, reimbursement follow-up, and escalations on denials. Dedicated helpdesk staffing conventions run around one claims executive per 8,000 to 12,000 covered lives, plus supervisory and medical-advisory overhead.

NHCX and digital workflows. The National Health Claims Exchange is standardising claims data exchange between providers, TPAs, and insurers, and corporates increasingly expect the broker's claims desk to track claims through NHCX-era statuses in near real time, reconcile TPA data against insurer data, and report turnaround against regulatory cashless expectations. That means portal integrations, claims MIS, and analysts who can read the data.

Stewardship and analytics. Quarterly claims reviews, renewal data packs, benchmarking, wellness calendars, and enrolment communication round out the load.

Fully costed, serviced group health accounts commonly consume INR 250 to 700 per member per year of broker operating cost depending on service depth. Set that against a 5 percent commission on a INR 6,000 per-life premium, which is INR 300 per member, and the margin question on any individual account stops being theoretical.

Take a 6,000-life account at INR 7,000 average premium per life: INR 4.2 crore of annual premium. The numbers are indicative of mid-market employee benefits economics in 2026.

Revenue. At a 6 percent commission the account yields INR 25.2 lakh. If the account has an OPD attachment and voluntary parental top-ups at higher commission rates, add INR 2 to 4 lakh. Total revenue roughly INR 27 to 29 lakh.

Cost to serve. Endorsement handling on roughly 5,000 to 7,000 annual member movements, a shared claims-desk allocation covering around 400 claims, an account manager at perhaps a quarter of capacity, enrolment support, stewardship reporting, and allocated technology and compliance overhead. Fully loaded, INR 15 to 22 lakh depending on depth and location.

Margin. Somewhere between INR 5 and 14 lakh, an 18 to 48 percent account margin, entirely dependent on operating discipline. Now stress it: a 1.5 point commission cut at renewal removes INR 6.3 lakh of revenue and most of the midpoint margin on its own; 15 percent premium inflation restores some of it but only if the rate holds.

Three conclusions follow. First, account-level margin visibility is not optional. Books where nobody can state the cost-to-serve of the top twenty accounts always contain loss-making relationships subsidised by two or three profitable ones. Second, service depth must be priced, not given away. An on-site helpdesk or a dedicated claims SPOC is a fee conversation, not a free retention gesture. Third, the endorsement and claims workload is the broker's best remuneration argument, because it is countable, auditable evidence of effort in exactly the form the regulator's emerging effort-based thinking rewards.

Book-level strategy is where group health economics are actually won. Five moves distinguish the employee benefits practices holding margin through the squeeze.

1. Segment the book by margin, not premium. Rank accounts by revenue minus cost-to-serve, not by premium handled. The standard finding is a profitable core, a large breakeven middle, and a loss-making tail of under-priced, over-serviced accounts. The tail gets repriced (higher commission, a service fee, or reduced service scope) or exited at renewal.
2. Convert servicing depth into fee lines. Claims desks, on-site helpdesks, flexible-benefits administration, wellness programme management, and analytics packs are separable services with market prices. Practices that moved 20 to 35 percent of employee benefits revenue into fees by FY2025-26 hold margin through commission cuts that damage pure-commission peers.
3. Manage the portfolio claims ratio as an asset. A broker book that consistently runs better than market on claims outcomes earns commission-scale credibility with every insurer, better renewal terms for clients, and pricing power on new business. That requires investment in claims analytics, network strategy, and plan-design honesty, funded from the margin it protects.
4. Balance the insurer panel. Concentrating a group health book with one or two insurers maximises short-term commission negotiating power but exposes the book to a single EOM or appetite shift. Three to five active markets per segment, with placement flows tied to service and commission performance, is the resilient shape.
5. Cross-sell the corporate relationship. Group personal accident, group term life placed through allied entities, GMC top-ups, and the commercial lines of the same corporate (property, liability, marine) all monetise the relationship the group health servicing effort built, at better yields than the anchor product itself.

The regulatory direction disclosed in July 2026 could reset group health commission economics more fundamentally than the EOM squeeze has. IRDAI has signalled a commission-rules overhaul aimed at curbing mis-selling, with a consultation paper expected by end July 2026 per Chairperson Ajay Seth: staggered or trail commissions across the policy life rather than upfront payment (upfront payouts reach around 40 percent on some life and health products), effort-based remuneration paying more for advisory, documentation, and claims servicing than for passive distribution, possible caps by product type, tenure, and complexity, and tighter disclosure. These are proposals under consultation, not rules.

For group health broking the effort-based idea cuts favourably. No distribution segment can document effort like an employee benefits practice: endorsement counts, claims-desk ticket logs, escalation outcomes, NHCX-tracked turnaround times, stewardship records. If remuneration tilts toward evidenced servicing, practices with instrumented operations and account-level costing can defend or improve their economics while passive channels lose share of the commission pool.

The disclosure side is equally consequential. The draft IRDAI (Insurance Intermediaries) (Amendment) Regulations, 2026, published for comment in June 2026 and still a draft, would require intermediaries to disclose intermediation revenue in a separate audited schedule, file financials with IRDAI by 30 September each year, and publish them, with stricter requirements above INR 10 crore of commission income. Combined with the commission-cap powers restored by the Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Act, 2025, in force from 5 February 2026, the direction is a market where group health remuneration is visible, evidenced, and earned.

The practices that win in that market are being built now: costed accounts, instrumented claims desks, fee lines for real services, and a portfolio claims ratio worth boasting about. The premium pool will keep growing; the brokerage pool will follow only those who can show the work.